Skip to main content
. 2021 Mar 7;10(5):1118. doi: 10.3390/jcm10051118

Table 1.

Baseline preoperative characteristics of the study population presented as mean ± standard deviation unless stated otherwise.

XEN-Implant (n = 124 Eyes) XEN-Implant Combined with Cataract Extraction (n = 97 Eyes) p-Value
Age (years) 69.9 ± 10.5 71.7 ± 9.7 0.181
Gender, female (n, %) 70 (56.5) 49 (50.5) 0.380
Caucasian descent (n, %) 111 (89.5) 81 (83.5) 0.270
Untreated IOP at diagnosis (mmHg) 22.4 ± 8.8 24.0 ± 10.1 0.195
IOP (mmHg) 20.0 ± 6.7 17.3 ± 5.8 0.002
Number of IOP-lowering Rx 3.1 ± 1.3 3.2 ± 1.0 0.834
Visual acuity 0.7 ± 0.4 0.7 ± 0.3 0.172
Spherical equivalent (D) * −1.3 ± 2.1 −2.0 ± 4.2 0.165
Central corneal thickness (µm) 528.9 ± 44.5 518.7 ± 57.8 0.251
Positive family history (n, %) 48 (39.3) 39 (41.5) 0.750
Follow-up (years) 1.7 ± 1.3 1.2 ± 0.9 <0.001
Previous eye surgery (n, %) # 20 (16.1) 5 (5.2) 0.011

* = before cataract surgery if applicable; # = cataract surgery not counted; NA = Not applicable/available; IOP = Intraocular pressure; Rx = Medication.